Search results
This up-and-coming cancer treatment could be a $25 billion market opportunity — it's already a...
NBC San Diego· 2 days agoTargeted radiopharmaceuticals has caught the eye of big pharma. The therapy delivers radiation...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 1 day ago“We are excited to announce that FG-3246 in combination with enzalutamide in patients with mCRPC...
Genetic cancer screening: Learning more about lesser known hereditary cancers
WTAE Pittsburgh· 5 days agoAccording to the National Cancer Institute, these inherited variants are thought to contribute to...
Docs support drug regulator’s move to withdraw Olaparib for some cancer patients
Investing.com· 2 days agoOlaparib is a chemotherapy drug and is used to treat certain kinds of cancers of the ovaries,...
... in Combination with anti-PD-1 for First Line Recurrent and/or Metastatic Head and Neck Cancer to...
FOX 5 San Diego· 14 hours agoRakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell-targeting photoimmunotherapy based on its proprietary Alluminox™ platform, today announced ...
Support Early Detection Technology to Save the Lives of Black Cancer Patients - Los Angeles Sentinel
Los Angeles Sentinel· 3 days agoThe stark reality that Black women are 41% more likely to die from breast cancer than White women is a grim reminder of the systemic inequities that pervade our health care ...
NCI-MATCH Precision Medicine Clinical Trial
National Cancer Institute· 1 day agoNCI-MATCH, also known as MATCH, is a precision medicine cancer treatment clinical trial that sought to find out if treating cancer based on specific...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 1 day agoSALT LAKE CITY, May 23, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, and its collaborators will share data from seven studies at the 2024 ASCO Annual Meeting. Three studies
IR-MED’s PressureSafe device cuts pressure injury incidence by half
Medical Device Network via Yahoo Finance· 2 days agoThe PressureSafe device reduced the incidence of pressure injuries by 50% by detecting these...
Forever Chemicals Now Found in Band-Aids
Mercola· 4 days agoBandages that you apply to open wounds may contain toxic polyfluoroalkyl or perfluoroalkyl chemicals, known collectively as PFAS. Bandages are only the latest consumer good found to contain ...
